Gallagher Brian M. Jr.
Insider CIK 1709976 · ALRN Director · TBIO Director · EFTR Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2024-06-13 | 2024-06-13 | 800 | — | $0 | 800 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2024-02-19 | 2024-02-21 | 2,000 | — | $0 | 2,000 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2023-06-22 | 2023-06-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2023-01-20 | 2023-01-24 | 50,938 | — | $0 | 50,938 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | P Buy | 2022-06-23 | 2022-06-27 | 30,000 | $1.59 | $47.7K | 30,000 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2022-06-09 | 2022-06-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2021-10-06 | 2021-10-08 | 40,000 | — | $0 | 40,000 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2021-10-06 | 2021-12-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2021-08-25 | 2021-08-27 | 605,338 | — | $0 | 605,338 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award | 2021-08-25 | 2021-08-27 | 4,822,114 | — | $0 | 4,822,114 | SEC↗ |
| TBIO Translate Bio, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-05 | 2,525,253 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-05 | 7,222,797 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-05 | 9,300,000 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | C Conversion | 2018-07-02 | 2018-07-05 | 1,674,016 | — | $0 | 1,674,016 | SEC↗ |
| TBIO Translate Bio, Inc. | P Buy | 2018-07-02 | 2018-07-05 | 269,230 | $13.00 | $3.50M | 3,697,912 | SEC↗ |
| TBIO Translate Bio, Inc. | C Conversion | 2018-07-02 | 2018-07-05 | 454,550 | — | $0 | 3,428,682 | SEC↗ |
| TBIO Translate Bio, Inc. | C Conversion | 2018-07-02 | 2018-07-05 | 1,300,116 | — | $0 | 2,974,132 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | A Award deriv | 2017-07-25 | 2017-07-27 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | C Conversion deriv | 2017-07-05 | 2017-07-06 | 1,471,551 | — | $0 | 0 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | C Conversion deriv | 2017-07-05 | 2017-07-06 | 1,276,389 | — | $0 | 0 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | C Conversion deriv | 2017-07-05 | 2017-07-06 | 1,979,188 | — | $0 | 0 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | C Conversion deriv | 2017-07-05 | 2017-07-06 | 6,781,770 | — | $0 | 0 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | C Conversion | 2017-07-05 | 2017-07-06 | 1,158,186 | — | $0 | 1,158,186 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | P Buy | 2017-07-05 | 2017-07-06 | 273,333 | $15.00 | $4.10M | 1,431,519 | SEC↗ |